GEHC
$71.11-1.21%
as of close, Oct 27, 2026
☾ AH $71.11 -1.21%
GE HealthCare Technologies Inc. Common StockStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPNasdaq-100 · 0.1% of QQQNasdaq Composite · 0.06% of ONEQS&P 500 · 0.05% of SPYRussell 1000 · 0.04% of IWBUS Stock Market · 0.04% of VTIRussell 3000 · 0.04% of IWVMSCI World · 0.04% of URTHMSCI ACWI · 0.03% of ACWI
GEHC — GE HealthCare Technologies Inc. Common Stock price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEDDEDEDEDEDEDEDEDEDEDEDEDEDED
60.065.070.075.080.085.090.0020.0M40.0M$71.11—20222023202420252026
2026-10-27
Price$71.11
MA20$67.06
MA50$67.21
Vol5.1M
Key stats#
Price data
- Price
- $71.11
- YTD price return
- -13.30%
- YTD total return
- -13.13%
- Next earnings
- Oct 28, 2026 · Before open
- Market cap
- 32.1B
- Enterprise value
- 40.6B
- Shares outstanding
- 451.7M
- 52W low
- $58.75
- 52W high
- $89.77
- From 52W high
- -20.79%
- From 52W low
- +21.04%
- 52W range
- 40%
- Beta
- 0.80
Volume
- Rel volume
- 1.37×
- 30D volume
- 3.7M
- 30D $ vol
- 246.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- +$6.4M
Form 4 transactions by trade date, as filed; latest on file 2026-05-22.
Fundamentals
- Sales (ttm)
- 21.3B
- Sales/share
- $47.08
- EPS (ttm)
- $4.35
- Book value/share
- $24.30
- Net margin
- 9.33%
- ROE
- 18.09%
- ROA
- 5.33%
- Debt / equity
- 0.92×
- Current ratio
- 1.26
Growth (CAGR, ttm) · 10Y
- Sales
- +6.52%+3.76%+4.32%n/a
- Net income
- -11.43%+2.73%-2.72%n/a
- FCF
- -3.16%-6.21%n/an/a
- Shares
- -1.07%-0.23%-0.11%n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -10.99%+2.67%-2.84%n/a
- Sales/share
- +7.67%+4.00%+4.44%n/a
- FCF/share
- -2.83%-6.33%n/an/a
- Book value/share
- +14.23%+15.88%-8.78%n/a
- Dividend/share
- +75.07%+78.46%n/an/a
- Price
- -9.25%+4.06%n/an/a
- Total return
- -9.06%+4.25%n/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 16.4×
- P/OI (ttm)
- 11.7×
- Fwd P/E
- 13.2×
- P/S (ttm)
- 1.5×
- P/B (mrq)
- 2.9×
- EV/EBITDA (fy)
- 12.2×
- EV/Sales (ttm)
- 1.9×
- Dividend yield (fwd)
- 0.23%
- Dividend yield (ttm)
- 0.20%
- Dividend/share (fwd)
- $0.16
- Buyback yield (realized, 1y)
- 1.07%
- Shareholder yield (realized, 1y)
- 1.26%
- Buyback yield (cash, ttm)
- 1.25%
- Shareholder yield (cash, ttm)
- 1.44%
Vs own 10Y history
- P/E
- 31st
- P/OI
- 17th
- P/S
- 13th
- P/B
- 13th
Bar = where today’s multiple sits in GEHC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-1.21%
5D
+1.25%
1M
+6.72%
3M
+16.34%
YTD
-13.30%
1Y
-9.24%
5Y
—
Recent filings#
- Sep 228-K · GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
- Aug 188-K · GE HealthCare appoints William Grogan as Chief Financial Officer
- Jul 29Earnings · Earnings release — EPS $1.13 vs $1.04 est. (+8.7%); revenue $5.29B (+6% y/y) 12.2%
- Jul 238-K · GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
Financial statements
Open full GEHC financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
